Sangrix
SGRX
4 hedge funds and large institutions have $47.1K invested in Sangrix in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
795,322% more capital inflows, than outflows
Capital inflows: $71.6K | Capital outflows: $9
100% more funds holding
Funds holding: 2 → 4 (+2)
2.44% more ownership
Funds ownership: 0.09% → 2.53% (+2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRT Financial
New York
|
+$44.4K |
| 2 |
StoneX Group
New York
|
+$24.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.07K |
| 4 |
SBI Securities
Tokyo,
Japan
|
+$239 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Caitong International Asset Management
Hong Kong
|
-$9 |
SGRX Hedge Fund Activity: Q2 2026 in Review
4 of the 8,395 institutional investors tracked by Wall St. Rank reported a position in Sangrix (SGRX) for Q2 2026, worth a combined $47.1K — up 1,469% from $3K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SGRX positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $44.4K. The largest seller was Caitong International Asset Management, cutting an estimated $9.
- 4 institutional investors held Sangrix (SGRX) as of Q2 2026, up from 2 in Q1 2026.
- Funds reported $47.1K of Sangrix stock for Q2 2026, up 1,469% quarter-over-quarter.
- 2 funds opened new Sangrix positions in Q2 2026 and 0 closed out, a net change of +2 holders.
- The largest Sangrix buyer in Q2 2026 was HRT Financial, an estimated $44.4K added.
- The largest Sangrix seller in Q2 2026 was Caitong International Asset Management, an estimated $9 sold.
Based on aggregated 13F filings for Q2 2026.